What volume of heparin (unfractionated heparin) sodium 5000 units/5ml should be administered subcutaneously twice a day for a patient prescribed 5000 units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heparin Sodium Dosing Calculation

Administer 5 mL subcutaneously twice daily, as the concentration is 5000 units per 5 mL, which equals exactly 5000 units per dose. 1

Calculation Method

  • The concentration provided is 5000 units/5 mL, which simplifies to 1000 units/mL 1
  • For a prescribed dose of 5000 units: 5000 units ÷ 1000 units/mL = 5 mL 1
  • This volume should be administered via deep subcutaneous (intrafat) injection using a fine needle (25 to 26 gauge) to minimize tissue trauma 1

Administration Guidelines

  • Use a different injection site for each administration to prevent the development of massive hematoma 1
  • The recommended sites are the arm or abdomen 1
  • A concentrated solution of heparin sodium is recommended for subcutaneous prophylactic dosing 1

Dosing Context for VTE Prophylaxis

  • The 5000 units BID (twice daily) regimen is the standard prophylactic dose for moderate-risk hospitalized patients 2, 1
  • For higher-risk patients (such as those weighing >100 kg, cancer patients, or hip fracture patients), every 8-hour dosing (5000 units three times daily) may be more appropriate 3, 4
  • The American College of Cardiology notes that subcutaneous heparin 5000 units twice to three times per day can be considered in patients with renal dysfunction where LMWH is contraindicated 2

Important Clinical Considerations

  • Monitoring of aPTT is not routinely required for prophylactic dosing, unlike therapeutic anticoagulation 4
  • However, be aware that even prophylactic doses can occasionally prolong aPTT, particularly with higher doses (7500-10,000 units BID) 5
  • Periodic platelet counts, hematocrits, and tests for occult blood in stool are recommended during the entire course of heparin therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Duration of Heparin Prophylaxis for Hip Fracture Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Heparin Dosing for VTE Prophylaxis Based on Weight

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the dosing recommendations for heparin (unfractionated heparin) in patients requiring anticoagulation?
What is the recommended heparin (unfractionated heparin) bolus dose for bridging therapy in patients with severe Multiple Sclerosis (MS) requiring temporary discontinuation of acitrom (acetylsalicylic acid)?
Can heparin be initiated at any dose for a patient with impaired renal function and requiring anticoagulation therapy?
What is the protocol for intravenous (IV) anticoagulation with unfractionated heparin (UFH)?
What is the recommended heparin (unfractionated heparin) drip protocol for a patient pending left heart catheterization (left heart cath)?
When should oral iron supplementation versus intravenous (IV) iron supplementation be used in patients with iron deficiency anemia, particularly those with chronic kidney disease (CKD), inflammatory bowel disease (IBD), or cancer?
What is the recommended management for a 38 weeks and 5 days pregnant woman experiencing labor pain, with a fetus who weighed 1700g at 30 weeks gestation?
What are the guidelines for managing a patient with ischemic stroke, including treatment and medication options?
What are the potential causes of persistent hyperamylasemia in a patient with Type 2 Diabetes Mellitus (T2DM) and normal ultrasound findings?
What are the guidelines for using Tofacitinib in patients with autoimmune diseases and a history of infections?
What are the latest updates and treatment options for a patient with Obstructive Sleep Apnea (OSA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.